STREAM is the first large-scale, multi-country clinical trial to investigate shortened regimens for multidrugresistant tuberculosis (MDR-TB), and the first phase III trial to test the efficacy and safety of Bedaquiline, a new drug with a novel mechanism of action, within a shortened treatment regimen.
The trial established a Community Engagement (CE) Plan. The CE program was implemented at thirteen research sites within the STREAM trial, in seven countries. This paper sets out a summary of the experiences of CABs in connection with the STREAM clinical trial. It underlines relevant aspects that may be useful when planning and/or engaging communities in research. In conclusion, the experiences gained during STREAM, lead to both growing confidence in CE as a valuable process and community participation in advocacy.
Recent Abstracts
Opinión pública frente a la política de alcohol: Colombia
Public Attitudes Towards Alcohol Policy: Colombia
2024 Activity Report – Brazil
Estimação do impacto de diferentes cenários de redução do consumo de álcool no…
Estimation of the impact of various scenarios of reduction of alcohol use in…
Relatório de Atividades 2024 – Brasil
The Future of Health Financing in Africa: The Role of Health Taxes
RESET Alcohol Initiative Case Study: Media Campaign Resonates with the Public in Mexico
RESET Alcohol Initiative Case Study: A Historic Win for Alcohol Policy in Brazil
Effects of Heat on Early Childhood Development